Celgene Corp (CELG)

CELG (NASDAQ:Drugs)
$112.61
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | CELG Avg Daily Volume: 4,931,300
Last Update: 11/26/14 - 4:00 PM EST
Volume: 0
YTD Performance: 33.29%
Open: $0.00
Previous Close: $112.61
52 Week Range: $66.85 - $112.82
Oustanding Shares: 798,704,188
Market Cap: 89,942,078,611
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 16 16 16 16
Moderate Buy 1 1 1 1
Hold 2 2 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.26 1.26 1.35 1.43
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 58.96
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
58.96 58.90 26.03
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
17.73% 37.81% 273.87%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.90 0.79 0.21
Net Income -0.40 0.65 0.18
EPS 2.00 0.84 0.22
Earnings for CELG:
EBITDA 2.35B
Revenue 6.49B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $0.87 $n.a. $3.26 $4.50
Number of Analysts 3 0 2 3
High Estimate $0.88 $n.a. $3.26 $4.94
Low Estimate $0.85 $n.a. $3.26 $4.27
Prior Year $0.67 $0.73 $2.68 $3.26
Growth Rate (Year over Year) 30.83% n.a.% 21.64% 38.14%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Robert Lang

 | Nov 25, 2014 | 10:00 AM EST

Selling option premium into Thanksgiving can be a lucrative strategy.

By

Jim Cramer

 | Nov 24, 2014 | 4:12 PM EST

This market provides a slew of reasons to buy right now.

By

Jim Cramer

 | Nov 21, 2014 | 1:12 PM EST

Don't get too excited bidding CMI and CAT.

By

Jim Cramer

 | Nov 18, 2014 | 4:04 PM EST

In this market, negativity is rarely being rewarded.

By

Jim Cramer

 | Nov 11, 2014 | 4:13 PM EST

Investors are seeing growth today in three areas.

By

Jim Cramer

 | Nov 10, 2014 | 1:35 PM EST

Beat the short-term crown in these three areas for the long term.

By

Gary Berman

 | Nov 4, 2014 | 11:35 AM EST

This beloved stock has triggered a long-term overbought signal again.

By

Jim Cramer

 | Oct 30, 2014 | 2:31 PM EDT

Still, it's a good time to review what's happening, so we never forget.

By

Jim Cramer

 | Oct 29, 2014 | 12:42 PM EDT

The Fed event can actually be good for many stocks.

By

Ed Ponsi

 | Oct 28, 2014 | 10:00 AM EDT

The next step is to know how much risk you can bear.

Monitise has announced the sale of additional stock to Telefonica, Santander and Master Ca...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.